Suche Medizinische Publikationen
Suche Abbildungen und Grafiken
Medizinprodukte - Labortechnik
Antidotarium (Stand 2012)
Phytokodex (Stand 2012)
Fachbücher
Patientenliteratur
Dia-Präsentation von Merck Gesellschaft mbH. Micardis(R) - MicardisPlus(R) - Hypertonie (38 Abbildungen) Übersicht Gesamtpräsentation zum Download (rechte Maustaste und "Ziel speichern unter..." klicken)
| ||||||||||||||||||
Abbildung 24: Antihypertensive Behandlungsziele The treatment of patients with hypertension requires the identification of all reversible risk factors (for example, smoking and diabetes), as well as antihypertensive therapy.1 The target should be to reduce SBP and DBP to at least 140/90 mmHg. However, there is convincing evidence that further reductions, if they can be achieved without causing side effects, are beneficial in most patients. Diabetics are at increased risk of cardiovascular events, and so blood pressure should be reduced to at least 130/80 mmHg.1 1. 2003 European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–1053. |
Abbildung 24: Antihypertensive Behandlungsziele
The treatment of patients with hypertension requires the identification of all reversible risk factors (for example, smoking and diabetes), as well as antihypertensive therapy.1 The target should be to reduce SBP and DBP to at least 140/90 mmHg. However, there is convincing evidence that further reductions, if they can be achieved without causing side effects, are beneficial in most patients. Diabetics are at increased risk of cardiovascular events, and so blood pressure should be reduced to at least 130/80 mmHg.1 1. 2003 European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–1053. |